Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma
- DOI
- 10.1182/blood.2025030190
- Published
- 2026-04-09
- Container
- Blood
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/blood.2025030190,
title = {Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma},
author = {Jeremy S. Abramson and David J. Straus and Nancy L. Bartlett and John M. Burke and Ryan C. Lynch and Eva Domingo Domenech and Brian Hess and Steven R. Schuster and Yuliya Linhares and Mitul Gandhi and Harsh R. Shah and Wojciech Jurczak and Alessandro Re and Uwe Hahn and H. Miles Prince and Wenchuan Guo and Griffith Davis and Linda Ho and Michelle Fanale and Christopher A. Yasenchak and Hun Ju Lee},
year = {2026},
journal = {Blood},
doi = {10.1182/blood.2025030190},
url = {https://doi.org/10.1182/blood.2025030190}
}RIS
TY - JOUR TI - Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma AU - Jeremy S. Abramson AU - David J. Straus AU - Nancy L. Bartlett AU - John M. Burke AU - Ryan C. Lynch AU - Eva Domingo Domenech AU - Brian Hess AU - Steven R. Schuster AU - Yuliya Linhares AU - Mitul Gandhi AU - Harsh R. Shah AU - Wojciech Jurczak AU - Alessandro Re AU - Uwe Hahn AU - H. Miles Prince AU - Wenchuan Guo AU - Griffith Davis AU - Linda Ho AU - Michelle Fanale AU - Christopher A. Yasenchak AU - Hun Ju Lee PY - 2026 JO - Blood DO - 10.1182/blood.2025030190 UR - https://doi.org/10.1182/blood.2025030190 ER -
APA
Abramson, J. S., Straus, D. J., Bartlett, N. L., Burke, J. M., Lynch, R. C., Domenech, E. D., Hess, B., Schuster, S. R., Linhares, Y., Gandhi, M., Shah, H. R., Jurczak, W., Re, A., Hahn, U., Prince, H. M., Guo, W., Davis, G., Ho, L., Fanale, M., Yasenchak, C. A., & Lee, H. J. (2026). Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood.2025030190
Source records
- crossref · retrieved 2026-09-27T04:07:28.159Z